Premium
Insulin glulisine: a new rapid‐acting insulin analogue
Author(s) -
Narendran Parth
Publication year - 2006
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.400
Subject(s) - medicine , tolerability , insulin , diabetes mellitus , insulin analog , pharmacology , endocrinology , human insulin , adverse effect
Insulin glulisine is the latest rapid‐acting insulin analogue to become available. Here Dr Narendran describes the results of clinical trials of its efficacy and tolerability, and considers its potential role in the management of diabetes. Copyright © 2006 Wiley Interface Ltd